The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,538,705 in first-year total cost, median $769,353.
Most frequent study sections
- Special Emphasis Panel[ZES1 LWJ-K (R)]2
Most frequent institutions
- NZUMBE EPIGENETICS1
- VALA SCIENCES, INC.1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2018 | NeuroPredict, A screening assay for chemicals that affect the differentiation of human neural cells.2R44ES026225-02 | ROUNTREE, MICHAEL | NZUMBE EPIGENETICS, OR | $786,459 | ZES1 |
| 2018 | Assay of chemicals for Parkinson's toxicity in human iPSC-derived neurons2R44ES026268-02 | MCDONOUGH, PATRICK M | VALA SCIENCES, INC., CA | $752,246 | ZES1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.